PEGS Europe - Protein and Antibody Engineering Summit

November 13–17, 2017
Lisbon, Portugal

Meet Genedata experts at PEGS Europe Protein Engineering Summit in Lisbon, Portugal.

Don't miss the opportunity to see how Genedata solutions efficiently support the whole biopharmaceutical R&D workflow, including screening and protein engineering, expression and purification, characterization and analysis of protein therapeutics, cell line design and development, bioprocess optimization, and quality control of biologicals.

To get more information about Genedata solutions, please contact info@genedata.com.

Recommended Oral Presentation

Design and Evaluation of Next-Generation Biologics for Cancer Immunotherapy
Maria Wendt, PhD, Head of Science, Genedata

Advancing Bispecifics - Innovative Bispecific Combinations
Thursday, November 16 | 10:05–10:35

Bi- and multi-specific antibodies, Ab-cytokine fusion proteins, non-Ig scaffolds, chimeric antigen receptors (CARs), engineered TCRs and TCR-based bispecific constructs can provide significant advantages for use in cancer immunotherapy. However, as highly engineered molecules they pose new design, engineering, cloning, expression, purification, and analytics challenges. Genedata Biologics enables the automated design, screening, production, and testing of large panels of these candidate therapeutic molecules and includes built-in tools for developability and manufacturability assessments.

Recommended Poster Presentations

Generation, Design and Evaluation of TCR-, TCR mimetic- and CAR-based Therapeutics for Cancer Immunotherapy
Maria Wendt, PhD, Head of Science, Genedata

High-throughput Screening, Design, Production, and Evaluation of Bi- and Multi-specific Antibodies, T cell Engagers and Antibody-Cytokine Fusions for Cancer Immunotherapy
Guido Cappuccilli, PhD, Scientific Consultant, Genedata

A Novel Integrated End-to-End Workflow System Enabling Increased Throughput in Bioprocess Development
Karine Maillard, PhD, Scientific Consultant, Genedata

Automated Data Processing for Quality Monitoring of Biotherapeutics by Multi-attribute Methods (MAMs)
Dominik Mertens, PhD, Scientific Consultant, Genedata

Enterprise Mass Spectrometry Software Solution Enabling Characterization of Biotherapeutics from Discovery and Development to Production and Quality Control
Jean Mercier, PhD, Scientific Consultant, Genedata

 


Links:
www.pegsummiteurope.com